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L-Citrulline shows potential activity as a supplement to prevent 
myocardial infarction through vasodilative and possible antioxidative effects 
but may be deleterious by causing nitrosative stress. This study determined 
the potentially deleterious effects of L-citrulline supplementation in 
isoproterenol-induced myocardial infarction with a focus on nitrosative 
stress. L-Citrulline supplementation was given orally at dosages of 300 or 
600mg/kg body weight daily for 6 days. Myocardial infarction was induced in 
Wistar rats via subcutaneous injection of isoproterenol (85 mg/kg body 
weight (BW)) on day 4 and 5. Blood pressure was measured at the end of the 
study (day 6) and rats were sacrificed to collect heart tissue samples for a 
histopathological evaluation. The histopathological evaluation was done 
using hematoxylin and eosin staining for the myocardial damage evaluation 
and immunohistochemical (IHC) staining of arginase-2, inducible nitric oxide 
synthase (iNOS), and 3-nitrotyrosine to evaluate nitrosative stress. L-
Citrulline supplementation failed to show a significant protective effect on 
blood pressure and exacerbated the decrease of diastolic blood pressure. Both 
low and high dose L-citrulline supplementation had a significant protective 
effect on myocardial damage compared to the isoproterenol group (p<0.01). 
L-Citrulline also caused increased nitrosative stress as shown by increased 
expression of arginase-2 and 3-nitrotyrosine on IHC staining but tended to 
show an ameliorative effect on iNOS expression. A significant increase in 
arginase-2 expression was detected between the high dose group and the 
other groups (p<0.01 vs. normal and isoproterenol groups; p<0.05 vs. low 
dose group). L-Citrulline supplementation increased 3-nitrotyrosine 
expression in a dose-dependent manner, which was significantly different 
compared to the normal group (low dose: p<0.013; high dose: p<0.003). L-
Citrulline increased the production of nitrosative stress but resulted in less 
myocardial damage through its other effects. 
Keywords: isoproterenol-induced myocardial infarct, L-citrulline, 
nitrosative stress 
 
 
INTRODUCTION 
Coronary heart disease (CHD) is a leading 
cause of death worldwide and acute myocardial 
infarction (AMI) is the most lethal complication 
(Wong, 2014). AMI is caused by an imbalance 
between supply and demand of oxygen to the 
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myocardium (Burke and Virmani, 2007). Organic 
nitrates, such as nitroglycerin and isosorbide 
dinitrate, are medications used to treat this 
imbalance. These medications act by donating 
nitric oxide (NO), which causes vasodilation; thus, 
restoring the oxygen supply to the myocardium. 
Unfortunately, organic nitrates are not meant to be 
used constantly because they cause nitrate 
tolerance and provide a diminishing vasodilative 
effect (Münzel, et al., 2013). L-Arginine is an amino 
acid in the endogenous NO cycle. L-Arginine 
supplementation increases the level of NO in the 
blood circulation by supplying a substrate used by 
endothelial nitric oxide synthase (eNOS), which is 
the principal mechanism of organic nitrates. L-
Arginine has been demonstrated to reduce blood 
pressure in prehypertensive and hypertensive 
patients (Figueroa, et al., 2017). L-Arginine causes 
no reduction of blood pressure in normotensive 
patients and can be used in a prolonged manner 
without causing nitrate tolerance. These effects 
alone show the potential of L-arginine as a 
supplement for patients at risk for CHD. L-Arginine 
also causes a reduction of monocyte adhesion and 
activity during inflammation (Adams, et al., 1997). 
Combined with this effect, L-arginine is a potential 
supplement to protect the myocardium in the event 
of AMI. The drawback of L-arginine 
supplementation is that it has poor oral 
bioavailability. To overcome this problem, 
supplementation is given using L-citrulline, which 
is a precursor. Unlike L-arginine, L-citrulline does 
not undergo extensive first-pass metabolism and 
provides better oral bioavailability than L-arginine 
itself (Kaore, et al., 2013). 
Another potential drawback of L-arginine 
supplementation is that in the event of high 
oxidative stress, such as ischemia, it may cause an 
increase in the formation of peroxynitrite. 
Peroxynitrite is a nitrosative species that causes 
nitrosative stress (Muntean et al., 2016). Coupled 
NOS uses L-arginine to form NO under 
physiological conditions. NOS is coupled with the 
help of tetrahydrobiopterin (BH4), which is 
oxidized to dihydrobiopterin (BH2) and loses its 
ability to couple with NOS. When uncoupled, NOS 
interacts with L-arginine to form peroxynitrite 
(Alkaitis and Crabtree, 2012). During this phase, an 
increase in the level of L-arginine translates 
directly to an increase in peroxynitrite (Cardounel, 
et al., 2005). Peroxynitrite is a mechanism used              
by monocytes during oxidative stress to produce 
inflammation. Monocytes produce inducible                 
NOS (iNOS), which increases exponentially              
during oxidative stress to help monocytes.                       
Monocytes increase expression of arginase-II as 
part of inflammation-induced immunosuppression. 
Arginase-II converts L-arginine to L-ornithine to 
reduce the amount of substrate metabolized   by 
uncoupled NOS (Munder, 2009). This study                   
used isoproterenol as a means to induce AMI in 
rats. Isoproterenol (L-β-(3,4-dihidrofenil)-α-
isopropylamino ethanol hydrochloride) is a 
medication used to treat heart failure based on its 
β-1 and β-2 receptor agonist activity. A high dose of 
isoproterenol increases the workload on the heart 
so that the oxygen demand of the myocardium 
outweighs the supply. The isoproterenol rat model 
has been extensively and reliably used to study the 
effect of substances on AMI (Liu et al., 2013). This 
study investigated the potentially deleterious 
effects of L-citrulline supplementation on 
isoproterenol-induced myocardial infarction with a 
focus on nitrosative stress. 
 
MATERIAL AND METHODS 
This study used 24 male Wistar rats            
(weight 190-220g) obtained from the Health 
Research and Development breeding                          
facility. This study was conducted according                
to the “Guide for the care and use of laboratory 
animals” and was approved by the Ethics 
Committee of The Faculty of Medicine, University of 
Indonesia. 
This study was conducted in the animal 
laboratory of Universitas Indonesia, Faculty of 
Medicine, Department of Pharmacology and 
Therapeutics. The rats were housed at a room 
temperature of 25°C, humidity of 55%, and a 12h 
light/dark cycle. The rats were given standard 
pellets and water ad libitum. After a 1 week 
acclimation, the rats were randomized into 4 
groups before the start of treatment: the normal 
group, which served as the sham group, receiving 
normal saline for MI induction and distilled water; 
the isoproterenol group, which served as the 
control group, receiving isoproterenol to induce MI 
and distilled water; and the low dose and high dose 
groups, receiving isoproterenol to induce MI and a 
daily dose of 300mg/kg BW and 600mg/kg BW L-
citrulline (NutriVita, Lake Forest, CA, USA), 
respectively. The L-citrulline in this study was 
diluted in distilled water and given by gavage. MI 
was induced by subcutaneously injecting 85mg/kg 
BW isoproterenol on days 4 and 5 of treatment with 
a 24h interval between injections. The 
isoproterenol was reconstituted in normal saline 
before injection. 
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The rats were anesthetized with an 
intraperitoneal injection of a mixture of 80mg/kg 
BW ketamine and 8mg/kg BW xylazine. Anesthesia 
was given before blood pressure measurements 
were taken on day 3 of treatment and day 6 before 
the final measurement and euthanasia. Ketamine 
and xylazine were chosen due to their ease of use 
and minimal interference with the blood pressure 
measurement. 
Blood pressure was measured under 
anesthesia on days 3 and 6 (end of treatment) of 
treatment using a CODA Scientific® non-invasive 
blood pressure device (Kent Scientific Corp., 
Torrington, CT, USA). Tissues were collected after 
the final blood pressure measurement was 
completed. Anesthetized rats were euthanized by 
supra cardiac puncture. After the rat was confirmed 
to be dead, a necropsy was done to collect the heart 
tissue sample. The dissected heart was washed 
with ice-cold saline, weighed, and photographed 
for documentation. A portion of heart tissue was 
cut and preserved in 10% neutral buffered 
formalin solution. The preserved heart tissue was 
then mounted in paraffin for hematoxylin and eosin 
(HE) and immunohistochemical (IHC) staining. 
The HE stained heart samples were scored 
for myocarditis by a blinded pathologist. Scoring 
was done using a slight modification to the method 
used by Gibson-Corley, Olivier, & Meyerholz, 
(2013). Myocarditis was scored based on the 
percentage of myocarditis foci, which reflected 
severity. Based on the percentage, the score was 
divided into 5 categories: 0 non-existent, 1 mild 
(10%), 2 moderate (30%), 3 severe (50%), and 4 
very severe (50−70%). The evaluation was done 
using a Leica DM 750 light microscope with 100x 
magnification (Leica Microsystems Inc., Buffalo 
Heights, IL, USA). 
The histological sample was cut to a width of 
3-5µM for IHC staining. After deparaffinization and 
rehydration, the sample was microwaved for 5min 
in 0.1M citrate buffer (pH 6.0). A solution of 3% 
hydrogen peroxide was added for 5min to remove 
endogen peroxides. The samples were then 
incubated with the respective antibodies: iNOS 
rabbit polyclonal antibody (1:200; Abcam Inc., 
Cambridge, MA, USA), arginase-II rabbit polyclonal 
antibody (1:100; Cell Signaling Technologies, San 
Diego, CA, USA), and 3-nitrotyrosine (1:500) in a 
phosphate buffered solution for 2h at room 
temperature in a humidity chamber and then 
overnight at 4°C. The FLEX Rabbit Negative Control, 
Ready-to-Use, (Dako Autostainer/Autostainer 
Plus; Dako, Carpentaria, CA, USA) was used as a 
negative control. The secondary antibody was 
added to the sample and incubated for 1h at room 
temperature, followed by the addition of HRP-
conjugated streptavidin and a 30min incubation. 
The proteins were visualized by adding 3,3'-
diaminobenzidine (DAB) to the sample followed by 
a 10min incubation. The samples were stained with 
Harris hematoxylin, dehydrated, and mounted. 
Regions of interest were evaluated. Protein 
expression was evaluated by comparing the 
percentage of area fraction stained with DAB as 
measured using ImageJ software (National 
Institutes of Health, Bethesda, MD, USA) with the 
immunohistochemistry toolbox plugin. The 
percentage of the area fraction was statistically 
analyzed (Jensen, 2013). 
Parametric data were analyzed using one-
way analysis of variance with Tukey’s post-hoc test. 
Non-parametric data were analyzed using the 
Kruskal–Wallis test and the Mann–Whitney test. 
The data are expressed as mean ± standard 
deviation for parametric data and as median 
(interquartile range) for non-parametric data. A p-
value <0.05 was considered significant.  
 
RESULT AND DISCUSSION 
AMI caused by isoproterenol results in 
myocardial damage that impairs heart contractility. 
This impairment manifests itself in the form of 
lower systolic and diastolic blood pressure. To 
compensate for the hypotension, the blood vessels 
contract to maintain blood pressure. Systolic and 
diastolic blood pressure decreased post induction 
in all induced groups (Table I). All induced groups 
were significantly different from the normal             
group (p<0.05). This result was in accordance                
with the study conducted by Anandan, et al.,  
(2015) where isoproterenol caused a decrease            
in blood pressure and protection against AMI             
was represented as an amelioration in this 
decrease. However, the decrease of blood          
pressure in both the low and high dose groups 
contradicted the supposed cardioprotective effect 
of L-citrulline against AMI. Because myocardial 
damage in both treatment groups was less severe 
than that in the isoproterenol group, these                
results were most likely caused by other                  
factors besides failed protection. L-Citrulline 
inhibits this contraction by donating NO to  
promote relaxation of vascular smooth                   
muscle. This condition followed the 
pharmacodynamic effect of L-citrulline supplemen-
tation in prehypertensive and hypertensive 
patients    shown   previously   (Wong  et al.,  2016).  
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These effects might explain whyL-citrulline 
supplementation did not prevent the decrease of 
blood pressure and tended to exacerbate it instead. 
However, these same effects may not necessarily 
help in the aftermath of AMI. Inhibited 
vasoconstriction, combined with decreased heart 
contractility may cause hypotension and 
hypoperfusion of organs, which can lead to organ 
failure and death (Metra et al., 2009). 
Isoproterenol caused myocardial damage, 
which was evaluated by scoring the percentage of 
myocarditis in the histopathological samples. 
Isoproterenol resulted in higher scores (Table II). 
The groups receiving isoproterenol scored 
significantly higher than the normal group (p < 
0.01). A significant difference also occurred 
between the groups receiving low and high dose L-
citrulline compared to the isoproterenol group (p< 
0.01; Figure 1). Isoproterenol caused significant 
damage across all induced groups, while the 
normal group remained free of damage, indicating 
that induction of AMI by isoproterenol was 
successful, as shown previously ( Filho et al.,2011). 
L-Citrulline supplementation failed to completely 
prevent the damage caused by AMI but ameliorated 
some damage as shown by the significantly lower 
myocarditis score compared to the isoproterenol 
group. 
L-Citrulline supplementation increased 
arginase-2 in a dose-dependent manner compared 
to the groups that were not supplemented. A 
significant increase was found between the high 
dose group and the remaining groups (p<0.01 vs. 
normal and isoproterenol groups; p<0.05 vs. low 
dose group) (Table II). Induction of AMI                         
with isoproterenol without L-citrulline 
supplementation resulted in slightly lower 
arginase-2 expression compared to the normal 
group although the difference was not significant. A 
histological representation of the samples (Figure 
2). A decrease of arginase-2 expression during 
inflammation is necessary to help monocytes 
produce inflammatory cytokines, namely 
peroxynitrite, using uncoupled iNOS (Schlüter,                     
et al., 2015). This might explain why the expression 
of arginase-2 was slightly lower in the 
isoproterenol group than that in the normal             
group. In contrast, increased arginase-2 expression 
during inflammation inhibits the production of 
nitrosative stress. This increased expression              
might be excess arginase-2 that was present             
before induction as a physiological response to 
metabolize excess L-arginine in circulation.                            
A more probable explanation is that monocytes 
expressed arginase-2 to control inflammation at a 
rate comparable to the level of circulating L-
arginine to prevent overproduction of 
peroxynitrite. This might explain the increase of 
arginase-2 in groups receiving L-citrulline 
supplementation. 
Isoproterenol administration resulted                      
in significantly higher expression of iNOS in                     
the isoproterenol and low dose groups               
compared  to  the normal  group  (p<0.01; Table II).  
Table I. Blood pressure measurements 
 
Group Systolic Blood Pressure (mmHg) Diastolic Blood Pressure (mmHg) 
Normal 177.44 ± 21.76 149.72 ± 21.35 
Isoproterenol 106.94 ± 25.55* 91.83 ± 5.49* 
Low Dose 108.08 ± 26.76* 87.73 ± 17.66* 
High Dose 92.89 ± 9.18* 68.27 ± 3.14* 
 
Data are presented as mean ± standard deviation; * p < 0.01 vs. normal group 
 
Table II. Immunohistochemical Evaluation Summary 
 
Group Hematoxylin-Eosin Scoring 
Arginase -2 
(% of area) 
INOS 
(% of area) 
3- Nitrotyrosine 
(% of area) 
Normal 0 (0–0) 7.86±3.32** 1.33±1.24 3.68±2.38 
Isoproterenol 4 (3.25–4)* 6.31±3.61** 3.24±2.57* 4.96±3.04 
Low Dose 2 (1.25–2)*, # 8.45±3.98** 2.81±2.33* 5.66±3.03* 
High Dose 2 (1.25–2)*, # 10.83±4.14 2.25±1.96 6.67±4.06* 
 
Data are presented as median (interquartile range) and mean ± standard deviation; *: significant difference vs. normal 
group (p <0.05); #(p < 0.05) vs. isoproterenol group; **Significant difference vs. high dose group (p <0.05) 
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High dose L-citrulline tended to ameliorate the 
increase of iNOS expression compared to that in the 
isoproterenol and low dose groups. Histological 
representation of the samples can be seen in Figure 
3. iNOS expression was elevated in all induced 
groups. L-Citrulline supplementation tended to 
ameliorate the increased expression in a dose-
dependent manner. The low dose group revealed a 
lower percentage of surface area compared to the 
isoproterenol group but it was significantly 
different from the normal group. iNOS expression 
in the high dose group tended to be higher than that 
 
 
Figure 1. Heart tissue (100x magnification; hematoxylin and eosin stain). A. Normal group; B. isoproterenol 
only group; C. isoproterenol + low dose L-citrulline group; D. isoproterenol + high dose L-citrulline group. 
White arrows are myocarditis foci, reflecting the severity of the myocardial infarction induced by 
isoproterenol. L-citrulline supplementation (C, D) can be seen ameliorating the number of myocarditis foci. 
 
 
 
Figure 2. Heart tissue (100× magnification; arginase-2 staining). A. Normal group; B. isoproterenol only 
group; C. isoproterenol + low dose L-citrulline group; D. isoproterenol + high dose L-citrulline group. 
 
 
 
Figure 3. Heart tissue (100× magnification; inducible nitric oxide synthase staining). A. Normal group; B. 
isoproterenol only group; C. isoproterenol + low dose L-citrulline group; D. isoproterenol + high dose L-
citrulline group. 
 
 
 
 
Figure 4. Heart tissue (100× magnification; 3-nitrotyrosine staining). A. Normal group; B. isoproterenol only 
group; C. isoproterenol + low dose L-citrulline group; D. isoproterenol + high dose L-citrulline group.  
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in the normal group but the difference was not 
significant. iNOS expression increases during AMI 
as part of the inflammatory mechanism (Liu et al., 
2013). The lower level of iNOS in the groups that 
received L-citrulline supplementation could have 
been caused by the reduced number of monocytes 
expressing iNOS, as a pharmacodynamic effect of 
an L-arginine surplus in circulation inhibits 
monocyte adhesion (Adams et al., 1997). 
3-Nitrotyrosine was used as a marker to 
measure nitrosative stress. Isoproterenol 
administration significantly increased the 
expression of 3-nitrotyrosine in all induced groups 
compared to the normal group (Table 2). L-
Citrulline supplementation caused a significant 
increase in 3-nitrotyrosine expression in a dose-
dependent manner compared to the normal group 
(low dose: p < 0.013; high dose: p < 0.003). A 
histological representation of the sample is shown 
in Figure 4. The increase in 3-nitrotyrosine 
expression was caused by nitrosative stress that 
occurred with oxidative stress during 
ischemia/reperfusion that caused AMI. The level of 
3-nitrotyrosine in groups receiving L-citrulline was 
even higher than that in the isoproterenol group in 
a dose-dependent manner. This increase of 3-
nitrotyrosine was caused by the increased amount 
of peroxynitrite produced because of the increased 
level of L-arginine in circulation. This result 
indicates that nitrosative stress during 
ischemia/reperfusion is exacerbated by L-citrulline 
supplementation, as reported previously (Mori, et 
al., 1998). 
Damage that resulted in AMI occurred 
because of the oxidative and nitrosative stress 
generated during ischemia/reperfusion. Both the 
low dose and high dose groups exhibited less 
myocardial damage but higher nitrosative stress 
than that in the isoproterenol group. This may have 
been caused by a shift in stress causing the damage. 
Increased nitrosative stress is caused by a shift of 
superoxide from forming H2O2 that caused 
oxidative stress and reacted with free NO to form 
peroxynitrite. This shift resulted in less total 
myocardial damage. 
 
CONCLUSION 
We conclude that L-citrulline 
supplementation in isoproterenol-induced MI 
caused more nitrosative stress but less myocardial 
damage. The lower myocardial damage may be 
partially attributed to a reduction in iNOS-
producing monocytes and the vasodilative effects 
of L-citrulline supplementation. However, the 
persistent vasodilative effect combined with 
decreased cardiac output may cause hypotension 
and hypoperfusion of organs. This study provides 
information regarding the potential benefit and 
risk of using L-citrulline supplementation to 
prevent AMI. 
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